Pictet Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.45M Buy
308,187
+298,931
+3,230% +$7.6M 0.01% 735
2026
Q1
$232K Sell
9,256
-64,371
-87% -$1.52M ﹤0.01% 1870
2025
Q4
$1.97M Buy
+73,627
New +$1.61M ﹤0.01% 907

Other funds holding ZYME

Pictet Asset Management's ZYME Position: Q2 2026 in Review

Pictet Asset Management increased its Zymeworks (ZYME) stake by 3,230% in Q2 2026, buying an estimated $7.6M and bringing the position to 308,187 shares worth $7.45M. The position accounts for 0.01% of the portfolio, ranked #735.

Pictet Asset Management first reported a position in ZYME in Q4 2025 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Pictet Asset Management held 308,187 shares of Zymeworks worth $7.45M as of Q2 2026.
  • Pictet Asset Management bought 298,931 Zymeworks shares in Q2 2026, an estimated $7.6M.
  • Zymeworks made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #735 holding.
  • Pictet Asset Management first reported a position in Zymeworks in Q4 2025 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.